New Strong Sell Stocks for June 26th
CHWY, FSM and MHO have been added to the Zacks Rank #5 (Strong Sell) List on June 26th, 2026.
Chewy vs. Central Garden & Pet: Which Pet-Care Stock Has an Edge?
CHWY is building on Autoship momentum, customer gains and vet-care expansion, while CENT drives growth through efficiency, margins and brand strength.
Chewy's Modern Animal Acquisition Strengthens Pet Healthcare Platform
Modern Animal gives CHWY a larger veterinary footprint, added clinical expertise and a faster path to clinic expansion in pet healthcare.
Chewy's Autoship Program Continues to Drive Customer Growth
CHWY's Autoship program drives recurring revenue growth, customer engagement and market share gains, reinforcing long-term momentum.
Chewy Stock Tumbles 45% in 3 Months: What Should Investors Do Now?
CHWY shares plunge 45% in three months as weaker spending and a lower sales outlook pressure growth despite market-share gains.
CHWY Is Tapping AI and Pet Health to Expand Margins in 2026
Chewy is leaning on pet health, AI and ads to widen fiscal 2026 margins, even as cautious consumers pressure sales and spending trends.
Is CHWY Stock a Buy After Its Selloff and Lower Revenue View
CHWY's sharp selloff and lower fiscal 2026 revenue outlook put its cheap sales multiple, Autoship strength and demand risks in focus.
Chewy Stock Outlook Hinges on Autoship and Pet Health Growth
Chewy's stock outlook rests on Autoship durability, pet health expansion and margin gains as cautious consumers pressure 2026 sales expectations.
CHWY's Push Into Veterinary Services Broadens Its Addressable Market
Chewy's vet care push is bringing in customers, boosting spending and expanding its reach in a $54B pet healthcare market.
Chewy's Autoship Business Continues to Drive Recurring Revenue Growth
CHWY's Autoship program outpaces overall sales growth in Q1, boosting recurring revenues as customer engagement and retention trends stay solid.
Chewy: Top Value Near 52-Week Lows
Chewy maintains a 'Strong Buy' rating despite lowering FY revenue guidance by $200M, citing macroeconomic headwinds. CHWY's acquisition of Modern Animal rapidly expanded its veterinary clinic footprint, positioning the pet health segment as a key growth and margin driver. Net sales per active customer rose 2.4% Y/Y to $597, with veterinary clinic expansion providing a catalyst for NSPAC and EBITDA margin growth.
Chewy Q1 Earnings Meet Estimates, Sales Beat on Autoship Strength
CHWY sales increase and margins expand in Q1, with Autoship strength supporting results as the company updates its 2026 outlook.
